Grace Therapeutics, Inc. Business Acquisition, Pro Forma Net Income (Loss)
Grace Therapeutics, Inc. (GRCE) reported Business Acquisition, Pro Forma Net Income (Loss) of -$13.73 million for the 12-month period ending 2022-03-31, per its 10-K filed 2023-06-23.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss · last filed 2023-06-23
- Grace Therapeutics, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2022-03-31 was -$4.06M.
- Grace Therapeutics, Inc. business acquisition, pro forma net income (loss) for the quarter ending 2021-12-31 was -$3.78M.
- Grace Therapeutics, Inc. business acquisition, pro forma net income (loss) for fiscal 2022 was -$13.73M.
| Period end | Business Acquisition, Pro Forma Net Income (Loss) 3 month | Business Acquisition, Pro Forma Net Income (Loss) 6 month | Business Acquisition, Pro Forma Net Income (Loss) 9 month | Business Acquisition, Pro Forma Net Income (Loss) 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$4.06M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-23 | -$7.84M derived: sum of 2 quarters · filed 2023-06-23 | -$13.73M 10-K · filed 2023-06-23 | |
| 2021-12-31 | -$3.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-14 | -$9.67M 10-Q · filed 2022-02-14 | ||
| 2021-09-30 | -$5.89M 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |